Publication | Open Access
Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review
17
Citations
23
References
2021
Year
TCZ in monotherapy, or combined with cDMARDs, is effective and safe in patients with refractory TAK of Caucasian origin.
| Year | Citations | |
|---|---|---|
Page 1
Page 1